Current Edition


Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets Immatics to Receive $54 Million Upfront, Milestone Payments …

Continue Reading →

Venus Medtech inks strategic partnership with Keystone Heart

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right …

Continue Reading →

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of …

Continue Reading →